WASHINGTON: A disease that vaccination programmes had brought under control for decades is making an alarming comeback, with Canada, the United Kingdom, Spain and now the United States losing their measles-elimination status following renewed transmission.
The latest development is the reported withdrawal of the United States' elimination status by the Pan American Health Organization (PAHO), ending a 26-year achievement after the same measles virus strain continued circulating in the country for more than 12 consecutive months.
The development is part of a wider public health concern extending beyond the United States, as several countries that had previously interrupted sustained domestic measles transmission are now facing renewed outbreaks.
Canada lost its measles-elimination status in November 2025 after a major outbreak that began in October 2024. The United Kingdom and Spain were among six European countries that also lost their elimination designations following assessments by World Health Organization (WHO) experts in January 2026.
The other affected European countries were Armenia, Austria, Azerbaijan and Uzbekistan.
The pattern raises an important question: Why are countries with established healthcare systems and long-running vaccination programmes struggling to keep measles under control?
The answer lies in a combination of declining immunisation coverage, gaps in community protection, vaccine hesitancy and the difficulty of maintaining elimination once the disease is no longer perceived as an immediate threat.
Public health authorities have repeatedly emphasised that high and consistent vaccination coverage, effective disease surveillance and timely outbreak response are essential to sustaining measles elimination.
What does losing measles-elimination status actually mean?
Losing elimination status does not mean that measles has suddenly spread throughout an entire country or that every imported infection represents a failure of its vaccination programme.
Measles elimination means that a country has interrupted continuous transmission of the virus within its borders. Imported cases can still occur through international travel without affecting elimination status, provided resulting outbreaks are contained and sustained local transmission does not become established.
The distinction is important because measles is highly contagious. When an infected traveller introduces the virus into a community with insufficient immunity, transmission can continue from person to person.
Under the international verification framework, the uninterrupted circulation of the same measles virus genotype and lineage for at least 12 months in a geographical area indicates the re-establishment of endemic transmission.
This is the key threshold behind the recent losses of elimination status.
In other words, countries do not lose their designation simply because they report measles cases. They lose it when they are unable to interrupt sustained domestic transmission.
Canada lost its status after a major outbreak
Canada became the first of the four countries in this recent sequence to lose its measles-elimination status.
The country had achieved elimination in 1998, but a multi-jurisdictional outbreak that began in October 2024 continued for more than a year, resulting in the loss of its designation on November 10, 2025.
The outbreak eventually affected more than 6,400 people across 10 provinces and territories, with most infections occurring among unvaccinated individuals.
Although the Public Health Agency of Canada declared the multi-jurisdictional outbreak over on October 19, 2026, the end of the outbreak did not automatically restore the country's elimination status.
Canada must demonstrate that transmission of the outbreak-associated strain has been interrupted for at least 12 consecutive months before it can regain the designation.
The distinction illustrates an important aspect of measles elimination: bringing an outbreak to an end is not necessarily the same as meeting the requirements for international re-verification.
UK and Spain among six European countries to lose status
The resurgence has also affected several countries in the WHO European Region.
In January 2026, WHO confirmed that six countries had re-established endemic measles transmission based on their epidemiological data for 2024. These were the United Kingdom, Spain, Armenia, Austria, Azerbaijan and Uzbekistan.
The findings reflected a wider resurgence of measles across Europe, where persistent immunity gaps had allowed the virus to circulate for extended periods.
The United Kingdom had previously achieved measles elimination in 2016, but lost the designation in 2018 following renewed transmission. It regained the status in 2021, partly following a substantial decline in measles circulation during the COVID-19 pandemic.
However, measles activity increased again from 2023, with a major outbreak in 2024 leading to the re-establishment of endemic transmission.
England recorded 2,911 laboratory-confirmed measles cases in 2024, its highest annual total since 2012. WHO subsequently confirmed that the UK no longer met the elimination criteria.
Spain also lost its elimination designation following the WHO's assessment of 2024 data. The decision reflected the inability to rule out a continuous chain of measles transmission lasting at least 12 months.
The six-country assessment demonstrates that the problem is not confined to countries experiencing exceptionally large outbreaks. Sustained transmission and weaknesses in surveillance and population immunity can also undermine elimination achievements.
US loses 26-year measles-elimination achievement
The United States is the latest major country to lose its measles-elimination status.
The country achieved elimination in 2000 after interrupting continuous domestic transmission, but a major resurgence has reversed that achievement.
According to a Wall Street Journal report cited by Reuters, PAHO withdrew the designation after determining that the same measles virus strain had circulated uninterrupted in the United States for more than 12 months.
The assessment involved epidemiological and laboratory evidence submitted by the US Centers for Disease Control and Prevention (CDC), including genetic analysis to establish whether infections represented sustained domestic transmission rather than separate imported cases.
The CDC's findings were presented to PAHO by Noel Brewer, a public health professor at the University of North Carolina who chairs an independent advisory panel on measles. The assessment remains confidential.
The resurgence has been particularly severe. The United States reported 5,412 confirmed measles cases in 2026 as of November 12, more than twice the 2,289 cases recorded throughout 2025.
Reuters reported that approximately 7,500 people had contracted measles and 13 had died in the United States since 2025.
The growing outbreak has coincided with declining childhood immunisation rates and increasing vaccine hesitancy.
The issue has also drawn attention to US Health Secretary Robert F. Kennedy Jr., who has repeatedly questioned vaccine safety without scientific evidence supporting claims that undermine the established safety and effectiveness of measles immunisation.
Before the reported decision, CDC Director Dr Erica Schwartz told Reuters that the agency would continue working with individual states to encourage immunisation and control outbreaks, adding that losing elimination status would not change its approach to measles prevention.
Noel Brewer described the scale of the resurgence as unacceptable given that measles is preventable through vaccination.
"It is a fully preventable disease. It is unconscionable that we have this amount of measles," Brewer said.
William Moss, an epidemiology professor at the Johns Hopkins Bloomberg School of Public Health, said the loss of elimination status was a blow to the United States' reputation as a public health powerhouse. He also warned that the development could discourage other countries.
The United States remains a member of PAHO despite withdrawing from the WHO.
Why is measles returning despite effective vaccines?
Declining vaccination coverage is one of the most important factors behind the renewed spread of measles.
Measles is among the most contagious human infectious diseases. A single infected person can transmit the virus to numerous susceptible individuals, particularly in crowded settings and communities where vaccination coverage is inadequate.
The disease can spread rapidly when it enters populations with immunity gaps, allowing infections to continue through successive generations of transmission.
The WHO recommends maintaining at least 95% coverage with two doses of measles-containing vaccine to prevent sustained transmission and protect communities.
However, vaccination coverage has fallen below this threshold in several countries experiencing renewed outbreaks.
According to WHO and UNICEF estimates, second-dose measles vaccination coverage across Europe and Central Asia stood at 91% in 2024, down from 92% in 2019. Coverage also varied considerably between countries and communities, leaving some populations particularly vulnerable.
In the United Kingdom, coverage for two doses among five-year-old children had fallen to approximately 83.7%, according to UK health authorities.
The problem is not necessarily that vaccines have become less effective. Rather, fewer people are receiving the recommended doses, leaving larger groups susceptible to infection.
Vaccine hesitancy, misinformation, declining confidence in immunisation, disruptions to routine vaccination programmes and unequal access to healthcare have all contributed to the challenge.
The COVID-19 pandemic also disrupted routine childhood immunisation services in many countries, while the subsequent recovery has not been sufficient to close all existing gaps.
The WHO has warned that persistent immunity gaps are allowing measles and other vaccine-preventable diseases to regain ground across different regions.
Why is the 95% vaccination target so important?
The 95% target is closely linked to the concept of herd immunity, also known as community immunity.
When a sufficiently high proportion of a population is immune to measles, the virus has fewer opportunities to spread from one person to another. This helps protect people who cannot receive vaccination for medical reasons and infants who are too young to complete their immunisation schedule.
Two doses of the measles vaccine provide approximately 97% protection against infection.
However, even a small decline in vaccination coverage can create significant vulnerabilities, particularly in densely populated communities, schools and households where people have frequent contact.
Importantly, achieving a national average of 95% does not guarantee protection in every community. Vaccination coverage must remain high and consistent across geographical areas and population groups.
A country may report high overall coverage while particular communities remain substantially under-vaccinated, allowing outbreaks to emerge and spread.
This is why public health authorities emphasise not only national immunisation figures but also identifying and reaching communities with lower vaccination coverage.
Measles is not a harmless childhood infection
The return of measles is particularly concerning because the disease can cause serious and sometimes life-threatening complications.
Although many patients recover, measles can lead to pneumonia, severe diarrhoea, dehydration, ear infections and inflammation of the brain, known as encephalitis.
Some complications can result in permanent disability, including blindness, deafness and brain damage. Severe infections can also lead to death, particularly among young children, malnourished individuals and people with weakened immune systems.
The disease is preventable through vaccination, making sustained outbreaks and avoidable deaths a significant public health concern.
The consequences also extend to healthcare systems, which must manage hospital admissions, complications, contact tracing, outbreak investigations and emergency vaccination campaigns.
What happens when countries lose elimination status?
Losing measles-elimination status is primarily an international public health classification, rather than a declaration that a country's entire population is experiencing an uncontrolled epidemic.
However, it signals that sustained domestic transmission has returned and that existing vaccination and disease-control efforts have not been sufficient to interrupt the spread.
The designation also serves as an indicator of the effectiveness of national immunisation programmes, disease surveillance and outbreak response systems.
For countries in the Americas, PAHO's Regional Verification Commission reviews epidemiological evidence, laboratory findings, vaccination coverage and the effectiveness of outbreak-control measures before making recommendations on elimination status.
The loss of regional measles-free status in November 2025 followed the re-establishment of endemic transmission in Canada. The United States' reported loss adds another major setback for the region.
For Europe, the six-country assessment based on 2024 data similarly highlighted the difficulty of maintaining elimination across a region where measles continues to circulate.
Can countries regain measles-elimination status?
Yes. Losing elimination status does not mean that a country can never regain it.
Countries must interrupt endemic transmission, maintain effective surveillance and demonstrate that the same virus strain is no longer circulating continuously.
Under the verification frameworks, at least 12 consecutive months without endemic transmission are required before a country can be considered for re-verification.
Brazil provides an example of how elimination can be restored. After losing its measles-elimination status in 2019, the country interrupted endemic transmission and regained its designation in 2024.
However, regaining the status requires more than bringing a single outbreak under control. Countries must demonstrate sustained interruption of transmission, strengthen routine immunisation and ensure that susceptible populations are protected.
For Canada, the end of its major outbreak in October 2026 is an important step, but it does not immediately restore its previous designation. The same principle applies to the United States and European countries seeking to regain elimination.
A warning that decades of progress cannot be taken for granted
The loss of measles-elimination status by Canada, the United Kingdom, Spain and the United States highlights a wider weakness in global efforts to control vaccine-preventable diseases.
These countries had demonstrated that sustained transmission could be interrupted through effective vaccination programmes, surveillance and public health interventions. Their recent setbacks show that such achievements require continuous investment and public confidence.
Measles elimination is not a permanent guarantee. When vaccination coverage falls, immunity gaps widen and surveillance or outbreak responses fail to contain transmission, the virus can regain a foothold.
The immediate priority for public health authorities is to close vaccination gaps, restore confidence in routine immunisation, strengthen surveillance and ensure that children and other vulnerable populations receive the recommended two doses.
The lesson is clear: controlling measles is not enough; countries must sustain the vaccination coverage and public health systems that keep it from returning.
Stay informed with Medical News Pakistan
CLICK HERE TO FOLLOW Medical News Pakistan on WhatsApp for verified global health breakthroughs, vaccine developments, infectious disease alerts, public health research, FDA approvals and critical healthcare updates from around the world.